An 86-year-old African-American woman with a history of well-controlled diabetes mellitus (HbA1c 6.4%), coronary artery disease, hypertension and Alzheimer's disease presented on 8 March with symptoms of fever, vomiting and dyspnoea of 24 hours' duration, and an episode of syncope 1 day before symptom onset. In the ED, his chest X-ray was irrelevant and a flu test was negative. She was febrile with 39.1°C and was admitted for observation. On 10 March, the patient showed worsening dyspnoea and was placed on nasal cannula oxygen therapy at 2L. A new chest X-ray showed ground-glass opacities, more severe in the right lung. C-reactive protein was 155.9 mg/dL. Nasopharyngeal swab sent for SARS-CoV-2 testing by qualitative PCR was positive. The patient developed respiratory failure and was transferred to the ICU on 12 March. She was placed on non-invasive ventilation. Urine Streptococcus pneumoniae antigen test collected on 12 March was positive and treatment was started with methylprednisolone (60 mg i.v. daily), azithromycin (500 mg i.v. daily), ceftriaxone (1 g i.v. daily) and hydroxychloroquine (initial dose 800 mg, then 400 mg i.v. daily). On 16 March, his respiratory status improved and he was discharged from ICU. On 18 March (symptomatology day 12), the patient again presented with worsening dyspnoea and hypoxaemia, with oxygen saturation of 86%, with a reservoir mask. The family made the decision to transfer the patient home with palliative care. She was discharged on 22 March and died at home on 23 March.

